ergoline has been researched along with Adenocarcinoma* in 1 studies
1 other study(ies) available for ergoline and Adenocarcinoma
| Article | Year |
|---|---|
Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer.
The stimulatory role of testosterone in the production and release of prostate-specific antigen (PSA) has been well characterized. Testosterone production by the testes is dependent on a functional hypothalamic-pituitary-gonadal axis. High prolactin levels have been shown to disrupt this axis, resulting in decreases in gonadotropins and testosterone levels. We report a patient with prostate cancer and elevated PSA levels followed with "watchful waiting" for several years who experienced a precipitous decrease in PSA level over a 3 month period. The patient was found to have an asymptomatic prolactin-secreting pituitary macroadenoma. Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents; Cabergoline; Ergolines; Humans; Male; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Prostate-Specific Antigen; Prostatic Neoplasms | 2006 |